Genetic Technologies Ltd Market Cap ($4.01 Million)
Market Cap & Net Worth: Genetic Technologies Ltd (GTG)
Genetic Technologies Ltd market cap. Genetic Technologies Ltd (AU:GTG) has a market capitalization of $4.01 Million (AU$5.67 Million) as of October 31, 2026. Listed on the AU stock exchange, this Australia-based company holds position #28981 globally and #1574 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genetic Technologies Ltd's stock price AU$0.04 by its total outstanding shares 145417246 (145.42 Million).
Genetic Technologies Ltd Market Cap History (2015–2026)
Genetic Technologies Ltd market cap history from 2015 to 2026. Data shows change from $229.41 Million to $4.01 Million (-28.64% CAGR). Check Genetic Technologies Ltd stock price for real-time trading data and today's change.
Genetic Technologies Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genetic Technologies Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Genetic Technologies Ltd (GTG) cash conversion ratio for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.52x
Genetic Technologies Ltd's market cap is 0.52 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $229.41 Million | $2.01 Million | -$8.81 Million | 114.02x | N/A |
| 2016 | $100.94 Million | $824.59K | -$8.46 Million | 122.41x | N/A |
| 2017 | $119.29 Million | $518.51K | -$8.40 Million | 230.07x | N/A |
| 2018 | $55.06 Million | $189.25K | -$5.46 Million | 290.92x | N/A |
| 2019 | $54.08 Million | $25.44K | -$6.83 Million | 2125.45x | N/A |
| 2020 | $73.74 Million | $9.86K | -$6.10 Million | 7475.94x | N/A |
| 2021 | $49.16 Million | $120.55K | -$7.08 Million | 407.80x | N/A |
| 2022 | $29.50 Million | $6.79 Million | -$7.13 Million | 4.34x | N/A |
| 2023 | $13.27 Million | $10.35 Million | -$11.75 Million | 1.28x | N/A |
| 2024 | $4.01 Million | $7.66 Million | -$12.02 Million | 0.52x | N/A |
Competitor Companies of GTG by Market Capitalization
Companies near Genetic Technologies Ltd in the global market cap rankings as of October 31, 2026. See Genetic Technologies Ltd (GTG) net asset quality to understand what proportion of total assets are financed by equity.
Key companies related to Genetic Technologies Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #136 globally with a market cap of $167.39 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #525 globally with a market cap of $51.71 Billion USD ( CN¥353.41 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $709.18 |
| #136 | Danaher Corporation | NYSE:DHR | $167.39 Billion | $236.98 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $436.00 |
| #525 | WuXi AppTec Co Ltd | SHG:603259 | $51.71 Billion | CN¥142.89 |
Market Capitalization of Genetic Technologies Ltd (2015–2026)
Market capitalization of Genetic Technologies Ltd from 2015 to today. Between 2015 and today, Genetic Technologies Ltd's market cap moved from $229.41 Million to $ 4.01 Million, with a yearly change of -28.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$4.01 Million | 0.00% |
| 2025 | AU$4.01 Million | 0.00% |
| 2024 | AU$4.01 Million | -69.77% |
| 2023 | AU$13.27 Million | -55.01% |
| 2022 | AU$29.50 Million | -40.00% |
| 2021 | AU$49.16 Million | -33.33% |
| 2020 | AU$73.74 Million | +36.36% |
| 2019 | AU$54.08 Million | -1.78% |
| 2018 | AU$55.06 Million | -53.85% |
| 2017 | AU$119.29 Million | +18.19% |
| 2016 | AU$100.94 Million | -56.00% |
| 2015 | AU$229.41 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of Genetic Technologies Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.01 Million USD |
| MoneyControl | $4.01 Million USD |
| MarketWatch | $4.01 Million USD |
| marketcap.company | $4.01 Million USD |
| Reuters | $4.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Genetic Technologies Ltd
Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through EasyDNA, AffinityDNA, and GeneType/Corporate segments. It offers BREVAGenplus, a clinicall… Read more